The global cell culture protein surface coating market size was valued at USD 313.7 million in 2015 and is projected to grow at 15.7% over the forecast period. The increasing interest of scientists and biotechnology companies in stem cell research is a major factor driving the growth of the market. Cell culture protein surface coating provides improved cell adhesion and growth of in vitro cell culture. Thus, the demand for these products is increasing, which is expected to propel the growth of the market during the forecast period. The stem cell is a very effective and promising therapy to treat several severe diseases such as cancer, brain diseases, cell deficiency therapy, and cardiovascular diseases. For instance, Parkinson's and Alzheimer's disease can be treated by replacing damaged cells and tissues.
In addition, increasing the adoption of 3D cell culture is a major factor considerably contributing to market growth. 3D cell culture is a process in which biological cells are grown in a controlled condition, wherein cells could interact with their surrounding across all three dimensions. The protein-coated cell culture instruments provide a 3D microenvironment to achieve optimal cell adhesion and proliferation. For example, Millicoat Extracellular Matrix (ECM)-Coated Plasticware delivers enhanced cell adhesion, proliferation, and differentiation of cells.
U.S. cell culture protein surface coating market by protein source, 2014 - 2025 (USD Million)
On the basis of type, the market is segmented into precoating and self-coating. In 2015, the self-coating segment was the highest revenue-generating segment. Rising investment in research and development is a key factor in boosting segment growth. The biotechnology and biopharmaceutical companies are focusing on the production of the monoclonal antibodies, protein therapeutics, induced pluripotent stem cells research, cryobanking, and cell-based assays development. Thus, the demand for the self-coating segment is also expected to remain high during the study period.
The precoating segment is expected to exhibit the fastest growth rate during the forecast period. This segment is classified into multiwall/microwell plates, flasks, Petri dishes, slides, and coverslips. The precoated cultureware provides several advantages such as it is ready-to-use, time-saving, delivers consistent quality, and improves isolation & cultivation of cells. Thus, the popularity of precoating cultureware is increasing, which is projected to boost the segment growth.
Asia Pacific cell culture protein surface coating market share, by coating type, 2015 (%)
The animal-derived material segment is reported to have a major revenue share of the cell culture protein surface coating market in 2015. The large application of these products in the production of biopharmaceutical products including monoclonal antibodies and recombinant proteins is the most predominant factor contributing to its highest share. On the other hand, the demand for human-derived protein products is also high due to its large application in insulin production. The increasing incidence of diabetes drives the demand for insulin. For instance, in 2015, about 415 million people were suffering from diabetes worldwide. Thus, the escalating incidence of diabetes boosts the growth of the human-derived protein segment.
The synthetic material segment is expected to exhibit the fastest growth rate during the study period. The growing demand for animal-free components is a prime factor attributing to the growth of this segment. Ethical and religious constraints on the application of animal-derived protein propel the adoption of synthetic proteins.
North America dominated the overall market in 2015 and is followed by Europe. The highly developed healthcare & research infrastructure and a large focus on drug discovery in North America have fueled the regional market. Moreover, the presence of advanced technology and the existence of leading biotechnology companies in this region drive the growth of the sector.
The Asia Pacific is expected to showcase the highest growth during the study period due to untapped opportunities in this region. There are many clinical research organizations and biopharmaceutical companies, which are targeting Asian countries, such as China & India for drug discovery and development. The availability of a vast genome pool, less stringent regulations for biologic product development, and developing healthcare infrastructure in this region are some of the major factors supporting the growth of the sector in this region.
Some of the key players in the market are Corning Inc.; Thermo Fisher Scientific, Inc.; Merck KGaA; PerkinElmer, Inc.; Greiner Bio-One International GmbH; BioVision, Inc.; and Trevigen Inc. The major companies are undertaking various strategies initiatives, such as new product launch, collaborations, mergers & acquisitions, and regional expansion for serving the unmet needs of their customers.
Strategic collaborations or acquisitions help vendors expand their product portfolio and geographical reach. For instance, in March 2014, Corning Inc., and American Type Culture Collection (ATCC) announced that they have extended their existing collaboration for the co-development of new applications for existing Corning’s and ATCC’s cell biology products.
Attribute |
Details |
Base year for estimation |
2016 |
Actual estimates/Historical data |
2014 - 2016 |
Forecast period |
2017 - 2025 |
Market representation |
Revenue in USD Million & CAGR from 2016 to 2025 |
Regional scope |
North America, Europe, Asia Pacific, Latin America & MEA |
Country scope |
U.S., Canada, U.K., Germany, India, China, Brazil, Mexico, South Africa |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
15% free customization scope (equivalent to 5 analyst working days) |
If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization |
This report forecasts revenue growth at global, regional & country levels and provides an analysis on the latest trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the cell culture protein surface coating market on the basis of coating type, protein source, and region:
Coating Type Outlook (Revenue, USD Million; 2014 - 2025)
Self-coating
Precoating
Multiwall/microwell plates
Petri dishes
Flasks
Slides
Coverslips
Protein Source Outlook (Revenue, USD Million; 2014 - 2025)
Animal-derived
Human-derived
Synthetic
Plant-derived
Regional Outlook (Revenue, USD Million; 2014 - 2025)
North America
The U.S.
Canada
Europe
Germany
The U.K.
Asia Pacific
China
India
Latin America
Brazil
Mexico
MEA
South Africa
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
Biopharmaceutical innovators are at the forefront of the human response to the coronavirus pandemic. A significant number of major biotech firms are in the midst of a race to investigate the Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the speed of response to SARS/MERs etc, the biotech entities are investigating SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are being put into the R&D. With multiple candidates in trial, the public and private sectors are anticipated to work in unison for the foreseeable period, until a vaccine is developed for Covid-19. The report will account for Covid19 as a key market contributor.